Adherence of Option B+ prevention of mother-to-child transmission program and its associated factors among pregnant and lactating mothers in public health facilities of East Gojjam zone, Amhara region, Ethiopia, 2017


  • Yezina Demelash Department of Medicine, College of Medicine, College of Health Sciences, Ethiopia
  • Nurilign Abebe Department of Public Health, College of Health Sciences, Ethiopia
  • Yewbmirt Sharew Department of Midwifery, College of Health Sciences, Debre Markos University, Debre Markos, Ethiopia
  • Tsegaye Mehare Department of Biomedical Science, College of Health Sciences and Medicine, Dilla University, Dilla



AIDS, Adherence, Antiretroviral


Background: Adherence of antiretroviral treatment (ART) among women on prevention of mother-to-child transmission (PMTCT) program is a central component to reduce viral loads and achieve elimination of mother to child transmission of human immunodeficiency virus (HIV) to Ethiopia. Option B+ PMTCT program is a recently introduced approach to eliminate new HIV infection among child. There is limited evidence on the drug adherence of women on ART in the Option B+ strategy. The aim was to assess adherence of Option B+ PMTCT drug and its associated factors among pregnant & lactating mothers in health facilities of East Gojjam zone, Amhara, Ethiopia, 2017.

Methods: Institution based cross-sectional study design was conducted from randomly selected three public health facilities in East Gojjam zone. Data was entered in to Epi data 3.1 and cleared then transferred to SPSS version 20 for analysis. To assess the associated factors, logistic regression model was employed. A p value <0.05 was considered statistically significant.  

Results: Adherence on Option B+ PMTCT drug was 75%. The likelihood of being adherence found to be significant association with the following variables: Mother’s educational status (AOR=2.03; 95%CI: 1.465, 8.918), partner occupation (AOR=4.73; 95%CI: 1.12, 19.87), time to reach to health facility (AOR=0.21; 95%CI: 0.05, 0.824), and maternal HIV knowledge (AOR=0.13; 95%CI: 0.03, 0.44).

Conclusions: Adherence to Option B+ PMTCT drug in East Gojjam zone, Amhara region was low compared to the national goal. Effort should be made both governmentally as well as non- governmentally to advance the knowledge about Option B+ PMTCT program so as to improve the long term maternal and child health.


Metrics Loading ...


van de Vijver D, Boucher CAB. Insights on transmission of HIV from phylogenetic analysis to locally optimize HIV prevention strategies. Curr Opin HIV AIDS. 2018;13(2):95-101.

Confronting a calamity. UN Chron. 1994;31(2):48-53.

Idele P, Hayashi C, Porth T, Mamahit A, Mahy M. Prevention of Mother-to-Child Transmission of HIV and Paediatric HIV Care and Treatment Monitoring: From Measuring Process to Impact and Elimination of Mother-to-Child Transmission of HIV. AIDS Behav. 2017;21(1):23-33.

Update AE. December 2009. Joint United Nations Programme on HIV/AIDS and World Health Organization. 2009.

Barker PM, Mate K. Eliminating mother-to-child HIV transmission will require major improvements in maternal and child health services. Health Aff. 2012;31(7):1489-97.

Obsa S, Dabsu R, Ejeta E. Egyptian Pediatric Association Gazette.

Keehn E, Karfakis J. Current practices to increase uptake, retention and adherence for Option B+ in Malawi. Lilongwe: mothers2mothers Malawi; 2014.

Organization WH. Programmatic update: use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: executive summary: Geneva: World Health Organization; 2012.

Ekama SO, Herbertson EC, Addeh EJ, Gab-Okafor CV, Onwujekwe DI, Tayo F, et al. Pattern and determinants of antiretroviral drug adherence among Nigerian pregnant women. J Pregnancy. 2012;2012:851810.

Tsegaye D, Deribe L, Wodajo S. Levels of adherence and factors associated with adherence to option B+ prevention of mother-to-child transmission among pregnant and lactating mothers in selected government health facilities of South Wollo Zone, Amhara Region, northeast Ethiopia, 2016. Epidemiol Health. 2016;38:e2016043.

Igwegbe A, Ugboaja J, Nwajiaku L. Prevalence and determinants of non-adherence to antiretroviral therapy among HIV-positive pregnant women in Nnewi, Nigeria. Int J Med Med Sci. 2010;2(8):238-45.

Mbirimtengerenji ND, Jere G, Lengu S, Maluwa A. Factors that influence anti-retroviral therapy adherence among women in Lilongwe urban health centres, Malawi. World J AIDS. 2013;3(3):16-25.

Ebuy H, Yebyo H, Alemayehu M. Level of adherence and predictors of adherence to the Option B+ PMTCT programme in Tigray, northern Ethiopia. Int J Infec Dis. 2015;33:123-9.

Markos E, Worku A, Davey G. Adherence to ART in PLWHA and Yirgalem Hospital, South Ethiopia. Ethiopian J Health Develop. 2008;22(2):174-9.






Original Research Articles